Jerry Chang
Plus aucun poste en cours
Profil
Jerry Chang worked as Director of Operations & Product Development at AxoGen Corp.
from 2010 to 2011.
He also worked as a Principal at Abbott Laboratories and Regeneration Technologies, Inc.
Anciens postes connus de Jerry Chang
| Sociétés | Poste | Fin |
|---|---|---|
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Directeur des opérations | 21/05/2010 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Regeneration Technologies, Inc.
 Regeneration Technologies, Inc. Medical SpecialtiesHealth Technology Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 2 |
|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Health Technology |
Regeneration Technologies, Inc.
Regeneration Technologies, Inc. Medical SpecialtiesHealth Technology Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL. | Health Technology |
